FDX1 and pheochromocytoma-paraganglioma: FDX1 levels in 11 other tumors were lower compared to normal tissues: adrenocortical carcinoma (ACC), breast invasive carcinoma (BRCA), cholangiocarcinoma (CHOL), head and neck squamous cell carcinoma (HNSC), kidney chromophobe (KICH), KIRC, kidney renal papillary cell carcinoma (KIRP), lung squamous cell carcinoma (LUSC), pheochromocytoma and paraganglioma (PCPG), testicular germ cell tumor (TGCT), and thyroid carcinoma (THCA) (p < 0.05).